- DocumentoHepatitis Bcaricato daRohit
- Documentoepigeneticscaricato daRohit
- DocumentoHER2Neu Kinase Compatiblecaricato daRohit
- DocumentoHER2Neu kinasecaricato daRohit
- DocumentoRole of LIMK1 in invasiveness and motility of cell in breast cancercaricato daRohit
- DocumentoMode of drugs actioncaricato daRohit
- DocumentoMonoclonal Pres Finalcaricato daRohit
- DocumentoProtein structurecaricato daRohit
- DocumentoRecent Developments in Vaccine Designscaricato daRohit
- DocumentoTypes of RNA'scaricato daRohit
- DocumentoLaws of Thermodynamicscaricato daRohit
- DocumentoPresentationcaricato daRohit
- DocumentoCytotoxicity of Novel Polyamine Conjugates on Breast Cancer Cellscaricato daRohit
- DocumentoImmunosuppression of Cyclosporine & OKT3caricato daRohit
- DocumentoRole of polyamines in breast cancercaricato daRohit
- DocumentoBangalore Dairycaricato daRohit
- DocumentoPrevalence, Incidence and Cost of Dementia Treatmentcaricato daRohit
- DocumentoEndpoints of Organ Transplantcaricato daRohit
- DocumentoRole of Board of Directorscaricato daRohit
- DocumentoDetection of ADR's & Importance of Pharmacovigilancecaricato daRohit
- DocumentoBio Markerscaricato daRohit
- DocumentoSmall Molecule Drug Discovery Presentationcaricato daRohit
- DocumentoReport on Aspirin Pharmacokinetics to Submitcaricato daRohit
- DocumentoOrgan Transplantcaricato daRohit
- DocumentoBusiness Model of Ranbaxy and Bioconcaricato daRohit
- DocumentoDrug Metabolism in Vitrocaricato daRohit
- Documento11-12-09 reportcaricato daRohit
- DocumentoPractical Report on the Pkacaricato daRohit
- DocumentoPharmacogenetics Polymorphism and Efficacy of Drugscaricato daRohit
- DocumentoDetecting ADRcaricato daRohit
- DocumentoDementia Presentation Finalcaricato daRohit
- DocumentoAdverse Drug Reactionscaricato daRohit
- DocumentoRanbaxy Laboratories Limitedcaricato daRohit
- DocumentoEnGeneICcaricato daRohit
- DocumentoEukaryotic Dna Replicationcaricato daRohit